RESUMEN

Mallory-Denk bodies (MDBs) are aggresomes composed of undigested ubiqutinated short lived proteins which have accumulated because of a decrease in the rate of their degradation by the 26s proteasome. The decrease in the activity of the proteasome is due to a shift in the activity of the 26s proteasome to the immunoproteasome triggered by an increase in expression of the catalytic subunits of the immunoproteasome which replaces the catalytic subunits of the 26s proteasome. This switch in the type of proteasome in liver cells is triggered by the binding of IFNγ to the IFNγ sequence response element (ISRE) located on the FAT10 promoter. To determine if either FAT10 or IFNγ are essential for the formation of MDBs we fed both IFNγ and FAT10 knock out (KO) mice DDC added to the control diet for 10weeks in order to induce MDBs. Mice fed the control diet and Wild type mice fed the DDC or control diet were compared. MDBs were located by immunofluorescent double stains using antibodies to ubiquitin to stain MDBs and FAT10 to localize the increased expression of FAT10 in MDB forming hepatocytes. We found that MDB formation occurred in the IFNγ KO mice but not in the FAT10 KO mice. Western blots showed an increase in the ubiquitin smears and decreases ß 5 (chymotrypsin-like 26S proteasome subunit) in the Wild type mice fed DDC but not in the FAT10 KO mice fed DDC. To conclude, we have demonstrated that FAT10 is essential to the induction of MDB formation in the DDC fed mice.

Asunto(s)

Modelos Animales de Enfermedad , Hepatocitos/efectos de los fármacos , Hígado/efectos de los fármacos , Cuerpos de Mallory/patología , Ubiquitinas/fisiología , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Dicarbetoxidihidrocolidina/toxicidad , Silenciador del Gen/fisiología , Hepatocitos/metabolismo , Hepatocitos/patología , Humanos , Interferón gamma/metabolismo , Hígado/metabolismo , Hígado/patología , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Noqueados , Tamaño de los Órganos/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Unión Proteica , Elementos de Respuesta/efectos de los fármacos , Elementos de Respuesta/fisiología , Especificidad de la Especie , Ubiquitina/metabolismo

RESUMEN

EZH2/H3K27me3 and polycomb group complex (PcG) play a major role in regulating global gene expression including tumor suppressor genes. EZH2 is linked to cell cycle regulated EZH2 phosphorylation by CDK1, a mitotic kinase which increases in arrested mitosis compared to S phase. CDK1 phosphorylation of EZH2 accelerates the degradation of pEZH2. Phospho-EZH2 is subjected to ubiquitination. The half-like of pEZH2 is shorter when compared to total EZH2. In the present study, pEZH2 was found concentrated together with ubiquitin in the Mallory-Denk bodies (MDB) that were formed in hepatocytes in the livers of drug primed mice refed DDC and humans with alcoholic hepatitis or hepatocellular carcinoma. The cells that formed MDBs in the mice livers studied were associated with a growth advantage and a high proliferative index. However, the livers from patients with alcoholic hepatitis showed evidence of cell cycle arrest where PCNA, cyclin D1 and p27 positive nuclei were numerous but Ki-67 positive nuclei were scarce. It is concluded that MDB formation is linked to the cell cycle and global gene expression (i.e. loss of gene silencing) through its association with the regulation of the polycomb group PRC2/EZH2/H3K27me3 complex.

Asunto(s)

Proteínas de Unión al ADN/metabolismo , Histonas/metabolismo , Hígado/metabolismo , Cuerpos de Mallory/metabolismo , Factores de Transcripción/metabolismo , Animales , Western Blotting , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Puntos de Control del Ciclo Celular , Núcleo Celular/efectos de los fármacos , Núcleo Celular/genética , Núcleo Celular/ultraestructura , Ciclina D1/metabolismo , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , Metilación de ADN , Proteínas de Unión al ADN/genética , Proteína Potenciadora del Homólogo Zeste 2 , Hepatitis Alcohólica/genética , Hepatitis Alcohólica/metabolismo , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hepatocitos/ultraestructura , Humanos , Inmunohistoquímica , Hígado/efectos de los fármacos , Hígado/patología , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Lisina/metabolismo , Cuerpos de Mallory/efectos de los fármacos , Cuerpos de Mallory/ultraestructura , Metilación , Ratones , Microscopía Electrónica , Complejo Represivo Polycomb 2 , Antígeno Nuclear de Célula en Proliferación/metabolismo , Piridinas/toxicidad , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , S-Adenosilmetionina/farmacología , Factores de Transcripción/genética

RESUMEN

Innate immunity factors such as conversion of the 26S proteasome to form the immunoproteasome and the Toll-like receptor signaling pathways are activated in chronic hepatitis induced by the carcinogenic drug DDC. Over time, preneoplastic hepatocyte phenotypes appear in the liver parenchyma. These changed hepatocytes expand in number because they have a growth advantage over normal hepatocytes when responding to chronic liver injury. The changed hepatocytes can be identified using immunofluorescent antibodies to preneoplastic cells e.g. FAT10/UbD, A2 macroglobulin, glutathione transpeptidase, alpha fetoprotein, glycipan 3, FAS, and gamma glutamyl transpeptidase. The formation of the preneoplastic cells occurs concomitant with activation of the Toll-like receptor signaling pathways and the transformation of the 26S proteasome to form the immunoproteasome. This transformation is in response to interferon stimulating response element on the promoter of the FAT10/UbD gene. NFκB, Erk, p38 and Jnk are also up regulated. Specific inhibitors block these responses in vitro in a mouse tumor cell line exposed to interferon gamma. Mallory-Denk bodies form in these preneoplastic cells, because of the depletion of the 26S proteasome due to formation of the immunoproteasome. Thus, MDB forming cells are also markers of the preneoplastic hepatocytes. The UbD positive preneoplastic cells regress when the liver injury induced chronic hepatitis subsides. When the drug DDC is refed to mice and chronic hepatitis is activated, the preneoplastic cell population expands and Mallory-Denk bodies rapidly reform. This response is remembered by the preneoplastic cells for at least four months indicating that an epigenetic cellular memory has formed in the preneoplastic cells. This proliferative response is prevented by feeding methyl donors such as S-adenosylmethionine or betaine. Drug feeding reduces the methylation of H(3) K4, 9, and 27 and this response is prevented by feeding the methyl donors. After 8 to 15months of drug withdrawal in mice the preneoplastic liver cells persist as single or small clusters of cells in the liver lobules. Multiple liver tumors form, some of which are hepatocellular carcinomas. The tumors immunostain positively for the same preneoplastic markers as the preneoplastic cells. Similar cells are identified in human cirrhosis and hepatocellular carcinoma indicating the relevance of the drug model described here to the preneoplastic changes associated with human chronic hepatitis and hepatocellular carcinoma.

Asunto(s)

Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/inmunología , Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/patología , Inmunidad Innata , Lesiones Precancerosas/inmunología , Animales , Carcinoma Hepatocelular/etiología , Carcinoma Hepatocelular/inmunología , Transformación Celular Neoplásica , Enfermedad Hepática Crónica Inducida por Sustancias y Drogas/complicaciones , Modelos Animales de Enfermedad , Hepatocitos/patología , Humanos , Neoplasias Hepáticas/etiología , Neoplasias Hepáticas/inmunología , Ratones , Ratones Endogámicos C3H

RESUMEN

BACKGROUND: Blood alcohol levels (BAL) cycle up and down over a 7-8 day period when ethanol is fed continuously for one month in the intragastric tube feeding rat model (ITFRM) of alcoholic liver disease. The cycling phenomenon is due to an alternating increase and decrease in the metabolic rate. Recently, we found that S-adenosyl-methionine (SAMe) fed with alcohol prevented the BAL cycle. METHOD: Using the ITFRM we fed rats betaine (2 g/kg/day) with ethanol for 1 month and recorded the daily 24 h urine ethanol level (UAL) to measure the BAL cycle. UAL is equivalent to BAL because of the constant ethanol infusion. Liver histology, steatosis and BAL were measured terminally after 1 month of treatment. Microarray analysis was done on the mRNA extracted from the liver to determine the effects of betaine and alcohol on changes in gene expression. RESULTS: Betaine fed with ethanol completely prevented the BAL cycle similar to SAMe. Betaine also significantly reduced the BAL compared to ethanol fed rats without betaine. This was also observed when SAMe was fed with ethanol. The mechanism involved in both cases is that SAMe is required for the conversion of epinephrine from norepinephrine by phenylethanolamine methyltransferase (PNMT). Epinephrine is 5 to 10 fold more potent than norepinephrine in increasing the metabolic rate. The increase in the metabolic rate generates NAD, permitting ADH to increase the oxidation of alcohol. NAD is the rate limiting factor in oxidation of alcohol by alcohol dehydrogenase (ADH). This explains how SAMe and betaine prevented the cycle. Microarray analysis showed that betaine feeding prevented the up regulation of a large number of genes including TLR2/4, Il-1b, Jax3, Sirt3, Fas, Ifngr1, Tgfgr2, Tnfrsf21, Lbp and Stat 3 which could explain how betaine prevented fatty liver. CONCLUSION: Betaine feeding lowers the BAL and prevents the BAL cycle by increasing the metabolic rate. This increases the rate of ethanol elimination by generating NAD.

Asunto(s)

Betaína/farmacología , Nutrición Enteral , Etanol/administración & dosificación , Etanol/sangre , Conducta Alimentaria/efectos de los fármacos , Alanina Transaminasa/sangre , Animales , Betaína/administración & dosificación , Peso Corporal/efectos de los fármacos , Colina/sangre , Etanol/orina , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Modelos Animales , Ratas , Ratas Wistar , Sarcosina/análogos & derivados , Sarcosina/metabolismo

RESUMEN

Recently it has been shown that the expression of the immunoproteasome increased in proportion to the degree of chronic inflammation in both the liver cell cytoplasm and nuclei in liver biopsies from patients who had chronic active hepatitis or cirrhosis. In the present study, biopsies from patients with steatohepatitis, with or without Mallory-Denk body (MDB) formation, were studied by immunofluorescent staining. Normal liver showed colocalization of FAT10, LMP2, LMP7, and MECL-1 at the mitochondria. Only LMP2 and LMP7 were found in the cell nuclei. Liver biopsies from patients with steatohepatitis and MDB formation, and a case of hepatocellular carcinoma forming MDBs in the tumor cells, showed colocalization of FAT10 and ubiquitin with LMP2, LMP7 and MECL-1 within the MDB. This indicates involvement of the immunoproteasome in MDB formation in steatohepatitis cases and in a case of HCC forming MDBs. Prior studies have shown that the immunoproteasome was involved in drug-induced MDB formation using the same immunofluorescent colocalization approach as was used on these human liver biopsies. The increase in the immunoproteasome subunit proteins was made at the expense of the 26S proteasome. This indicates that the shift from the 26S to the immunoproteasome had occurred in the MDB positive hepatocytes.

Asunto(s)

Carcinoma Hepatocelular/metabolismo , Hígado Graso/metabolismo , Inmunoproteínas/metabolismo , Neoplasias Hepáticas/metabolismo , Proteínas/metabolismo , Carcinoma Hepatocelular/patología , Núcleo Celular/metabolismo , Cisteína Endopeptidasas/metabolismo , Citoplasma/metabolismo , Hígado Graso/patología , Técnica del Anticuerpo Fluorescente Indirecta , Hepatitis Alcohólica/metabolismo , Hepatitis Alcohólica/patología , Humanos , Cirrosis Hepática/metabolismo , Cirrosis Hepática/patología , Neoplasias Hepáticas/patología , Mitocondrias Hepáticas/metabolismo , Proteínas Musculares/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo

RESUMEN

Betaine, a methyl donor active in methionine metabolism, is effective in preventing and reversing experimental alcohol liver disease. The metabolic and molecular biologic mechanisms involved in this prevention are only partially known. To further investigate how betaine modifies the effects of ethanol on the liver, rats were given an acute ethanol bolus with or without betaine and the results were compared to isocaloric dextrose-fed controls. Livers were subjected to microarray analysis, and functional pathways and individual gene expression changes were analyzed. Experimental groups were compared by Venn diagrams showing that both ethanol and betaine caused a change in the expression of a large number of genes indicating that the changes were global. The bio-informatic analysis showed that all the KEGG functional pathways were affected and mainly down regulated at 3 h post bolus when ethanol plus betaine were compared with ethanol-fed rats. The most profound effect of betaine was on the metabolic pathways both at 3 and 12 h post bolus. At 3 h, the changes in gene expression were mostly down regulated, but at 12 h, the changes were regulated equally up and down. This hypothesis-driven analysis showed that the effects of betaine on the effects of ethanol were partly transient.

RESUMEN

S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver. The following parameters were studied to determine the effects of SAMe; liver histology, the blood alcohol cycle (BAL), changes in gene expression mined from microarray analysis, changes in histone methylation, changes in liver SAMe levels and its metabolites and ADH. SAMe changed the type of fatty liver, reduced liver ALT levels and prevented the BAL cycle caused by intragastric ethanol feeding. Microarray analysis showed that SAMe feeding prevented most of the changes in gene expression induced by ethanol feeding, presumably by inducing H3K27me3 and gene silencing. H3K27me3 was significantly increased by SAMe with or without ethanol feeding. It is concluded that SAMe feeding stabilized global gene expression so that the changes in gene expression involved in the blood alcohol cycle were prevented.

Asunto(s)

Etanol/administración & dosificación , Etanol/sangre , S-Adenosilmetionina/administración & dosificación , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Modelos Animales de Enfermedad , Expresión Génica/efectos de los fármacos , Histonas/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Hepatopatías Alcohólicas/etiología , Hepatopatías Alcohólicas/genética , Hepatopatías Alcohólicas/metabolismo , Hepatopatías Alcohólicas/prevención & control , Masculino , Metilación , Análisis de Secuencia por Matrices de Oligonucleótidos , Ratas , Ratas Wistar , S-Adenosilmetionina/metabolismo

RESUMEN

Propranolol, a beta adrenergic blocker prevents the blood alcohol (BAL) cycle in rats fed ethanol intragastrically at a constant rate by preventing the cyclic changes in the metabolic rate caused by fluctuating levels of norepinephrine released into the blood. The change in the rate of metabolism changes the rate of alcohol elimination in the blood which causes the BAL to cycle. Microarray analysis of the livers from the rats fed ethanol and propranolol showed similar changes in clusters of functionally related gene expressions. The controls and the trough of the cycle differed dramatically from the cluster pattern seen in the rats at the peaks of the blood alcohol cycle. The changes in gene expression induced by ethanol were similar when propranolol was fed without ethanol especially with the changes in the kinases and phosphatases, Toll-like receptor signaling and cytokine-cytokine receptor interaction were also changed. The changes in gene expression caused by ethanol and propranolol feeding are alike probably because both drugs induce beta adrenergic receptor desensitization.

Asunto(s)

Antagonistas Adrenérgicos beta/farmacología , Etanol/sangre , Expresión Génica/efectos de los fármacos , Hepatopatías Alcohólicas/tratamiento farmacológico , Hígado/efectos de los fármacos , Propranolol/farmacología , Administración Oral , Animales , Modelos Animales de Enfermedad , Etanol/administración & dosificación , Perfilación de la Expresión Génica , Hígado/metabolismo , Hepatopatías Alcohólicas/genética , Hepatopatías Alcohólicas/metabolismo , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Transducción de Señal

RESUMEN

BACKGROUND: Gene expression changes in the liver after acute binge drinking may differ from the changes seen in chronic ethanol feeding in the rat. The changes in gene expression after chronic ethanol feeding may sensitize the liver to alcohol-induced liver damage, which is not seen after acute binge drinking. METHODS: To test this hypothesis, gene microarray analysis was performed on the livers of rats (n = 3) fed an acute binge dose of ethanol (6 g/kg body wt) and killed at 3 and 12 hours after ethanol by gavage. The gene microarrays were compared with those made on the liver of rats from a previous study, in which the rats were fed ethanol by intragastric tube for 1 month (36% of calories derived from ethanol). RESULTS: Microarray analysis data varied between the acute and chronic models in several important respects. Growth factors increased mainly in the chronic alcohol fed rat. Changes in enzymes involved in oxidative stress were noted only with chronic ethanol feeding. Gene expression of fat metabolism was increased only with chronic ethanol feeding. Most importantly, epigenetic related enzymes and acetylation and methylation of histones changed only after chronic ethanol feeding. CONCLUSIONS: The results support the concept that chronic ethanol ingestion induces altered gene expression as a result of changes in epigenetic mechanisms, where acetylation and methylation of histones were altered.

Asunto(s)

Alcoholismo/genética , Alcoholismo/metabolismo , Depresores del Sistema Nervioso Central/farmacología , Etanol/farmacología , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Acetilación/efectos de los fármacos , Enfermedad Aguda , Animales , Enfermedad Crónica , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Epigénesis Genética/efectos de los fármacos , Epigénesis Genética/fisiología , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Hepatocitos/citología , Histonas/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Hígado/citología , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Metilación/efectos de los fármacos , Análisis de Secuencia por Matrices de Oligonucleótidos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Ratas , Ratas Wistar

RESUMEN

Aggresome formation in cells involves the failure of the ubiquitin-proteasome pathway to dispose of proteins destined for degradation by the 26S proteasome. UBB(+1) is present in Mallory bodies in alcoholic liver disease and in aggresomes formed in Alzheimer's desease. The present investigation focuses on the role that UBB(+1) plays in cytokeratin aggresome formation in Mallory bodies (MBs) in vitro. Immunoprecipitation with a monoclonal antibody to cytokeratin-8 (CK-8) was used. The immunoprecipitate was incubated for 24 h in the presence of different constituents involved in aggresome formation including ubiquitin, UBB(+1), the proteasome inhibitor PS341, an ATP generating energy source, a deubiquitinating enzyme inhibitor, a purified proteasome fraction, and an E(1-3) conjugating enzyme fraction. MB-like protein aggregates formed in the presence of ubiquitin, plus UBB(+1) or PS341. These aggregates stained positively for CK-8. UBB(+1), and a proteasome subunit Tbp7, as demonstrated on Western blots. A second approach was used to form MBs in vitro in cultured hepatocytes transfected with UBB(+1) protein using Chariot. The cells were double stained using CK-8 and ubiquitin antibodies. The two proteins colocalized in MB-like aggregates. The results support the possibility that aggresome formation is a complex multifactor process, which is favored by inhibition of the proteasome and by the presence of UBB(+1).

Asunto(s)

Hepatocitos/metabolismo , Queratinas/metabolismo , Complejo de la Endopetidasa Proteasomal , Ubiquitina/genética , Ubiquitina/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Células Cultivadas , Proteínas de Unión al ADN/metabolismo , Hepatocitos/ultraestructura , Inmunohistoquímica , Cuerpos de Inclusión/química , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/ultraestructura , Masculino , Ratones , Ratones Endogámicos C3H , Mutación , Péptido Hidrolasas/metabolismo , Factores de Transcripción/metabolismo

RESUMEN

Mallory bodies are cytokeratin-ubiquitin aggresomes that form in hepatocytes in many different chronic liver diseases. One of the key components in aggresome formation, not yet investigated in Mallory body formation, is the role of microtubules. An in vitro tissue culture assay is required to test for microtubule involvement in Mallory body formation so that Mallory body formation can be observed in the presence or absence of microtubule-disrupting agents. In this report, a new model of in vitro Mallory body formation was developed, which uses cultured hepatocytes isolated from drug-primed mice. When hepatocytes were incubated in the presence of antimicrotubule agents, they failed to form Mallory bodies. It is concluded that intact microtubules are required for Mallory body formation.

Asunto(s)

Hepatocitos/patología , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/patología , Queratinas/metabolismo , Hígado/patología , Microtúbulos/fisiología , Animales , Anticuerpos/metabolismo , Células Cultivadas , Colchicina/farmacología , Dihidropiridinas/farmacología , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hepatocitos/ultraestructura , Cuerpos de Inclusión/química , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/ultraestructura , Lumicolchicinas/farmacología , Masculino , Ratones , Ratones Endogámicos C3H , Microtúbulos/efectos de los fármacos , Nocodazol/farmacología , Ubiquitina/metabolismo

RESUMEN

Mallory bodies (MBs) are aggresomes, composed of cytokeratin and various other proteins, which form in diseased liver because of disruption in the ubiquitin-proteasome protein degradation pathway. Heat shock proteins (hsp's) are thought to be involved in this process because it was discovered that MB formation is induced by heat shock in drug-primed mice. It has been reported that ubiquitin and a mutant form of ubiquitin (UBB(+1)) are found in aggresomes formed in the neurons in Alzheimer's disease and in the liver MBs in various liver diseases. In addition, hsp 70 has been found in aggresomes in Alzheimer's and in MBs in drug-primed mice. Therefore, we hypothesized that hsp's might be involved in MB formation in human liver diseases. Liver biopsy sections were double-stained using ubiquitin and hsp 70 or 90b antibodies. Both hsps 70 and 90b were found in MBs in all liver diseases investigated including primary billiary cirrhosis, nonalcoholic steatohepatitis, hepatitis B and C, idiopathic cirrhosis, alcoholic hepatitis, and hepatocellular carcinoma. Ubiquitin and the hsp's colocalized in all MBs in the diseased liver sections. These results indicate that hsp involvement in MB formation is similar to that seen in aggresome formation in other conformational diseases.

Asunto(s)

Proteínas de Choque Térmico/metabolismo , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/patología , Queratinas/metabolismo , Hígado/patología , Animales , Anticuerpos/metabolismo , Biopsia , Clormetiazol/farmacología , Dihidropiridinas/farmacología , Moduladores del GABA/farmacología , Proteínas de Choque Térmico/química , Humanos , Cuerpos de Inclusión/química , Queratinas/análisis , Hígado/efectos de los fármacos , Hepatopatías/metabolismo , Hepatopatías/patología , Masculino , Ratones , Ratones Endogámicos C3H , Modelos Biológicos , Ubiquitina/metabolismo

RESUMEN

Aggresomes form in cells when intracellular proteins undergo conformational changes, as in so-called conformational diseases. This phenomenon has been observed in the liver and brain and in cell culture in response to abnormal protein formation, such as mutant proteins. In the case of the brain the frameshift mutant ubiquitin (UBB+1) is involved. Mallory body formation in the liver is one example of this phenomenon in vivo. Mallory body formation is common in a variety of liver diseases of diverse pathogenesis. The study of the Mallory body forming model indicated that drug-conditioned hepatocytes form Mallory bodies when mice are given colchicine, ethanol, okadaic acid, or exposure to heat shock. These findings suggest that aggresome formation is a common pathway of liver injury due to diverse mechanisms. To further characterize the role of this common pathway, drug-primed mice were exposed to different types of liver injury, i.e., using such drugs as thioacetamide, galactosamine, tautomycin, and the proteasome inhibitor PS341. Mallory body formation was induced by treatment with all the toxins tested, giving credence to the proposal that aggresome formation in the liver is a common pathway in response to different primary mechanisms of liver injury. The frameshift mutant UBB+1 was invariably found to colocalize with ubiquitin in the Mallory body, indicating its essential involvement in the mechanism of MB formation.

Asunto(s)

Cisteína Endopeptidasas/genética , Hígado/efectos de los fármacos , Complejos Multienzimáticos/genética , Piranos , Compuestos de Espiro , Ubiquitina/genética , Animales , Antifúngicos/toxicidad , Ácidos Borónicos/toxicidad , Bortezomib , Mutación del Sistema de Lectura , Galactosamina/toxicidad , Hepatocitos/efectos de los fármacos , Hígado/patología , Hígado/ultraestructura , Masculino , Ratones , Ratones Endogámicos C3H , Microscopía Fluorescente , Complejo de la Endopetidasa Proteasomal , Proteínas/análisis , Pirazinas/toxicidad , Tioacetamida/toxicidad

RESUMEN

The intragastric tube feeding model of alcoholic liver disease in the rat induces significant liver histopathology, including steatohepatitis and fibrosis. The question is, if the same low-carbohydrate diet is fed ad lib, will the same pathology develop? Rats were fed a liquid diet with ethanol ad lib that was low in calories derived from carbohydrates for 2 months. The urinary ethanol levels (UALs) were monitored at hourly, daily, and weekly intervals, and the growth of the rats was charted. The liver histopathology and blood transaminase levels were determined. Rats fed ethanol grew 1 g/day, which was 2 g/day less than when they were fed the same diet intragastrically. UALs varied hourly between 150 and 500 mg%, daily between 120 and 360 mg%, and weekly between 0 and 500 mg%. Individual rat UALs showed no predictable pattern. The pair-fed controls ate all of their daily ration within 12 h, then fasted until the next day. The histopathology and blood alanine aminotransferase were similar to those seen with the intragastric tube feeding of the same diet, except that necrosis, inflammation, and fibrosis did not develop. The conclusion was that the oral feeding of a low-carbohydrate diet produces less liver injury than that produced by the same diet fed intragastrically. The UALs varied hourly, daily, and weekly in individual rats, making it difficult to synchronize UALs at the time of sacrifice.

Asunto(s)

Carbohidratos de la Dieta/administración & dosificación , Etanol/administración & dosificación , Hepatitis Alcohólica/etiología , Administración Oral , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Citocromo P-450 CYP2E1/metabolismo , Activación Enzimática/efectos de los fármacos , Etanol/sangre , Etanol/orina , Hepatitis Alcohólica/enzimología , Hepatitis Alcohólica/patología , Técnicas para Inmunoenzimas , Hígado/enzimología , Masculino , Ratas , Ratas Wistar , Factores de Tiempo

RESUMEN

This article represents the proceedings of a symposium at the 2000 ISBRA Meeting in Yokohama, Japan. The chairs were Samuel W. French and R. J. Mayer. The presentations were (1) The ubiquitin-proteasome 26s pathway in liver cell protein turnover: Effect of alcohol and drugs, by Samuel W. French and F. Bardag-Gorce; (2) The role of CYP2E1 phosphorylation and degradation pathway in the induction of the enzyme, by Magnus Ingelman-Sundberg; (3) Role of proteasome in the proteolysis of oxidized proteins in experimental chronic alcoholism, by Helen Rouach; (4) Alcohol, proteolysis and liver cancer, by R. J. Mayer; (5) Effect of ethanol feeding on the ATP-ubiquitin-proteasome pathway in the liver cell, by F. Bardag-Gorce; (6) Novel mechanisms and targets for intracellular transport of CYP2E1, by E. Neve; and (7) Gankyrin, an oncoprotein commonly over expressed in hepatoma, by H. Higashitsuji.

Asunto(s)

Depresores del Sistema Nervioso Central/farmacología , Citocromo P-450 CYP2E1/efectos de los fármacos , Etanol/farmacología , Hepatocitos/efectos de los fármacos , Péptido Hidrolasas/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal , Ubiquitinas/efectos de los fármacos , Animales , Carcinoma Hepatocelular/metabolismo , Quimotripsina/efectos de los fármacos , Quimotripsina/metabolismo , Citocromo P-450 CYP2E1/metabolismo , Hepatocitos/metabolismo , Humanos , Hígado/efectos de los fármacos , Hígado/metabolismo , Neoplasias Hepáticas/metabolismo , Ratones , Péptido Hidrolasas/metabolismo , Ratas , Ubiquitinas/metabolismo

RESUMEN

Mallory bodies (MBs) are aggregates of proteins, principally cytokeratin proteins found in liver cells. They are also found in a few other cell types such as type II pneumocytes and trophoblasts. Studies on the liver thus far indicate that MBs are derived from hyperphosphorylated, heavily ubiquitinated proteins which have undergone conformational change. The aggregated protein may accumulate because of the failure of the proteasome to remove the altered proteins from the cytoplasm of liver cells. To investigate this possibility, the proteasomes were assessed immunohistochemically in individual liver cells of mice fed a drug which induced MB formation. To accelerate and enhance MB formation, cytochrome P450 2EI knockout mice were used. Proteasomes in individual cells were visualized by immunofluorescence using an antibody to a subunit of the proteasome (P25). The results showed that the groups of liver cells that had formed MBs were often partially depleted of proteasomes. These findings support the possibility that MBs formed as a result of the loss of the proteasome to remove misfolded cytokeratin proteins. Thus MBs may share their pathogenesis with other types of cellular inclusions seen where proteins aggregate in the cytoplasm due to mutation, misfolding, or loss of proteasomes.

Asunto(s)

Cisteína Endopeptidasas/deficiencia , Hepatocitos/metabolismo , Cuerpos de Inclusión/metabolismo , Hígado/metabolismo , Complejos Multienzimáticos/deficiencia , Animales , Citocromo P-450 CYP2E1/genética , Modelos Animales de Enfermedad , Hepatocitos/patología , Cuerpos de Inclusión/patología , Queratinas/metabolismo , Hígado/patología , Ratones , Ratones Endogámicos , Ratones Noqueados , Microscopía Confocal , Fosforilación , Complejo de la Endopetidasa Proteasomal , Conformación Proteica , Proteínas/metabolismo , ARN Mensajero/metabolismo , Ubiquitinas/metabolismo

RESUMEN

The present investigation was undertaken to determine the effect of CYP2E1 induction by ethanol on the inhibition of proteasomal activity in wild-type and CYP2E1 knockout C57 black mice. The proteasomal chymotrypsin-like activity decreased significantly in ethanol-fed wild-type mice liver, but was not reduced in ethanol-fed knockout mice liver. The 26S proteasomal activity was decreased more by ethanol feeding than was the 20S proteasomal fraction. Individual hepatocytes lost immunostaining of the proteasomes in the centrilobular zone in the livers of ethanol-fed wild-type mice and the knockout mouse liver. There was increased product of protein oxidation in the liver in the wild type but not in the knockout mice given ethanol. Taken together, these results suggest that CYP2E1 induction was responsible for the decrease in proteasome activity seen in the wild-type mice which head to the accumulation of oxidized proteins which were increased as the result of free radicals generated by CYP2E1 metabolism of ethanol.

Asunto(s)

Citocromo P-450 CYP2E1/metabolismo , Etanol/farmacología , Complejos Multienzimáticos/antagonistas & inhibidores , Animales , Cisteína Endopeptidasas , Citocromo P-450 CYP2E1/biosíntesis , Citocromo P-450 CYP2E1/genética , Inducción Enzimática , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Complejo de la Endopetidasa Proteasomal

RESUMEN

Muscular functions decline and muscle mass decreases during ageing. In the rat, there is a 27% decrease in muscle protein between 18 and 34 months of age. We examined age-related changes in the proteasome-dependent proteolytic pathway in rats at 4, 18, 24, 29 and 34 months of age. The three best characterised activities of the proteasome (chymotrypsin-like, trypsin-like and peptidylglutamyl peptide hydrolase) increased to 29 months and then decreased in the senescent animal. These variations in activity were accompanied by an identical change in the quantity of 20S proteasome measured by Western blot, whereas the S4 subunit of the 19S regulator and the quantity of ubiquitin-linked proteins remained constant. mRNA of subunits C3, C5, C9, and S4 increased in the senescent animal, but ubiquitin mRNA levels were unchanged. These findings suggest that the 20S proteasome may be partly responsible for the muscular atrophy observed during ageing in the rat.

Asunto(s)

Envejecimiento/metabolismo , Cisteína Endopeptidasas/metabolismo , Complejos Multienzimáticos/metabolismo , Músculo Esquelético/metabolismo , Animales , Atrofia , Western Blotting , Peso Corporal , Cisteína Endopeptidasas/genética , Femenino , Masculino , Complejos Multienzimáticos/genética , Músculo Esquelético/enzimología , Músculo Esquelético/patología , Complejo de la Endopetidasa Proteasomal , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas , Ubiquitinas/genética , Ubiquitinas/metabolismo